Up a level |
Journal Article
Cremer, Sebastian, Jakob, Carolin, Berkowitsch, Alexander, Borgmann, Stefan, Pilgram, Lisa, Tometten, Lukas, Classen, Annika, Wille, Kai ORCID: 0000-0002-7682-8563, Weidlich, Simon, Gruener, Beate, Dimmeler, Stefanie, Massberg, Steffen, Rieg, Siegbert and Zeiher, Andreas M. . Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry. Clin. Res. Cardiol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1861-0692
Cremer, Sebastian, Pilgram, Lisa, Berkowitsch, Alexander, Stecher, Melanie, Rieg, Siegbert, Shumliakivska, Mariana, Bojkova, Denisa, Wagner, Julian Uwe Gabriel ORCID: 0000-0002-3863-854X, Aslan, Galip Servet ORCID: 0000-0002-5084-1241, Spinner, Christoph, Luxan, Guillermo, Hanses, Frank, Dolff, Sebastian, Piepel, Christiane, Ruppert, Clemens, Guenther, Andreas, Ruthrich, Maria Madeleine, Vehreschild, Jorg Janne, Wille, Kai ORCID: 0000-0002-7682-8563, Haselberger, Martina, Heuzeroth, Hanno, Hansen, Arne, Eschenhagen, Thomas, Cinatl, Jindrich, Ciesek, Sandra, Dimmeler, Stefanie, Borgmann, Stefan and Zeiher, Andreas (2021). Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLoS One, 16 (10). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203
Scholz, Alexander, Harter, Patrick N. ORCID: 0000-0001-5530-6910, Cremer, Sebastian, Yalcin, Burak H., Gurnik, Stefanie, Yamaji, Maiko, Di Tacchio, Mariangela, Sommer, Kathleen, Baumgarten, Peter, Baehr, Oliver, Steinbach, Joachim P., Trojan, Joerg, Glas, Martin, Herrlinger, Ulrich, Krex, Dietmar, Meinhardt, Matthias, Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Timmer, Marco, Goldbrunner, Roland, Deckert, Martina, Braun, Christian, Schittenhelm, Jens, Frueh, Jochen T., Ullrich, Evelyn ORCID: 0000-0001-8530-1192, Mittelbronn, Michel, Plate, Karl H. and Reiss, Yvonne (2016). Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol. Med., 8 (1). S. 39 - 58. HOBOKEN: WILEY-BLACKWELL. ISSN 1757-4684